Herbert W. Virgin

Herbert W. "Skip" Virgin has served in academic, industry, and foundation roles related to infectious diseases, virology, immunology and genetics. He served as the Edward Mallinckrodt Professor and Chair of the Department of Pathology & Immunology at the Washington University School of Medicine and is a member of the National Academy of Sciences. He is best known for establishing murine norovirus as a model system for studying norovirus biology, for identifying host phenotypes associated with persistent viral infections, and for defining alterations to the human virome in the context of different diseases, for elucidating the roles of autophagy and interferon-stimulated genes during viral infection. He supervised the discovery of, and assisted with the development of, multiple therapeutics for infections while at Vir Biotechnology, including the monoclonal antibody sotrovimab which received emergency use authorization during the SARS-CoV-2 pandemic. He is currently leading the AI Enabled Cures Frontier program at the Gates Foundation. Provided by Wikipedia